Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

• Yunda Huang,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Dean Follmann,

  Affiliation National Institute of Allergy and Infectious Diseases and Biostatistics Research Branch, National Institutes of Health, Bethesda, MD, United States of America

  ⨯
• Martha Nason,

  Affiliation Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America

  ⨯
• Lily Zhang,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Ying Huang,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Devan V. Mehrotra,

  Affiliation Merck Research Laboratories, North Wales, PA, United States of America

  ⨯
• Zoe Moodie,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Barbara Metch,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Holly Janes,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Michael C. Keefer,

  Affiliation Infectious Disease Division, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America

  ⨯
• Gavin Churchyard,

  Affiliation Aurum Institute for Health Research, Johannesburg, South Africa

  ⨯
• Merlin L. Robb,

  Affiliation HJF HIV Program, US Military HIV Research Program, Bethesda, MD, United States of America

  ⨯
• Patricia E. Fast,

  Affiliation Research and Development, International AIDS Vaccine Initiative, New York, New York, United States of America

  ⨯
• Ann Duerr,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• M. Juliana McElrath,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Lawrence Corey,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• John R. Mascola,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America

  ⨯
• Barney S. Graham,

  Affiliation Viral Pathogenesis Laboratory, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America

  ⨯
• Magdalena E. Sobieszczyk,

  Affiliation Division of Infectious Diseases, Department of Medicine, Columbia University, New York, New York, United States of America

  ⨯
• James G. Kublin,

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Michael Robertson,

  Affiliation Infectious Disease Clinical Research, Merck, Philadelphia, Pennsylvania, United States of America

  ⨯
• Scott M. Hammer,

  Affiliation Division of Infectious Diseases, Department of Medicine, Columbia University, New York, New York, United States of America

  ⨯
• Glenda E. Gray,

  Affiliation University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Susan P. Buchbinder,

  Affiliation Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States of America

  ⨯
•  [ ... ],
• Peter B. Gilbert

  * E-mail: pgilbert@scharp.org

  Affiliation Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• [ view all ]
• [ view less ]